| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 88,913 | 91,145 | 140,664 | 127,337 |
| Marketable securities | 641,245 | 700,007 | 475,256 | 522,636 |
| Prepaid expenses and other current assets | 17,297 | 12,746 | 11,248 | 11,619 |
| Total current assets | 747,455 | 803,898 | 627,168 | 661,592 |
| Property and equipment, net | 1,070 | 1,159 | 1,228 | 1,289 |
| Right-of-use assets, operating leases | 967 | 1,096 | 1,220 | 1,340 |
| Other assets | 721 | 726 | 840 | 840 |
| Total assets | 750,213 | 806,879 | 630,456 | 665,061 |
| Accounts payable | 11,759 | 9,018 | 7,268 | 6,350 |
| Accrued external research and development expenses | 12,137 | 11,451 | 7,705 | 7,463 |
| Other accrued expenses | 6,827 | 15,561 | 11,115 | 6,161 |
| Operating lease liabilities, current | 419 | 611 | 656 | 632 |
| Total current liabilities | 31,142 | 36,641 | 26,744 | 20,606 |
| Principal term loan balance | 30,000 | 30,000 | 30,000 | - |
| Unamortized debt discount and issuance costs | 1,254 | 1,351 | 1,450 | - |
| Accrued end of term fee | 619 | 510 | 398 | - |
| Long-term debt, net | 29,365 | 29,159 | 28,948 | 28,737 |
| Operating lease liabilities, non-current | 1,277 | 1,253 | 1,373 | 1,553 |
| Total liabilities | 61,784 | 67,053 | 57,065 | 50,896 |
| Common stock, 0.0001 par value 100,000,000 shares authorized as of march 31, 2026 and december 31, 2025 38,190,464 and 37,890,616 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively | 4 | 4 | 4 | 3 |
| Additional paid-in capital | 1,262,686 | 1,249,043 | 1,022,324 | 1,001,223 |
| Accumulated other comprehensive (loss) income | -571 | 965 | 718 | 273 |
| Accumulated deficit | -573,690 | -510,186 | -449,655 | -387,334 |
| Total stockholders' equity | 688,429 | 739,826 | 573,391 | 614,165 |
| Total liabilities and stockholders' equity | 750,213 | 806,879 | 630,456 | 665,061 |
Disc Medicine, Inc. (IRON)
Disc Medicine, Inc. (IRON)